MAPT and Alzheimer disease: For instance, isoorientin restores normal cognitive performance in experimental animals by lowering numerous unique pathological hallmarks of AD such as amyloid β protein (Aβ) deposition, tau hyperphosphorylation and neuroinflammatory responses [132].